50
Participants
Start Date
August 6, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
CDC-9 IRV adjuvanted with alhydrogel for IM administration in 0.5 mL is comprised of single human rotavirus for protection against rotavirus infection
7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
CDC-9 IRV adjuvanted with alhydrogel for IM administration in 0.5 mL is comprised of single human rotavirus for protection against rotavirus infection
Placebo
0.5 mL sterile saline administered via IM injection
Emory Children's Center - Vaccine Research Clinic, Atlanta
Emory-Children's Center
OTHER
Bill and Melinda Gates Foundation
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
Centers for Disease Control and Prevention
FED